Sign In
Buy DCGO
$0.651
-0.0163 (-2.44%)
At Close: Jul 31, 2026
DocGo Announces First Quarter 2025 Results
04:05pm, Thursday, 08'th May 2025
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced fin
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues
DocGo to Announce First Quarter Results on Thursday, May 8, 2025
07:35am, Monday, 21'st Apr 2025
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that the Company will release
NEW YORK and NEW ORLEANS , April 18, 2025 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues
DocGo Earns Great Place To Work Certification™ For the Third Time in a Row
07:35am, Monday, 31'st Mar 2025
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced that it has been Certified™
DocGo Announces Upcoming Participation at Needham Virtual Healthcare Conference
07:35am, Monday, 24'th Mar 2025
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, today announced that Lee Bienstock, Chief Executive Officer, will p
DocGo: I'm Still On The Fence On This One
07:37am, Saturday, 08'th Mar 2025
DocGo's shares have plummeted over 45% since mid-February, declining over 20% after reporting Q4 '24 on February 27th. The company has relied on contingencies such as COVID-19 testing and large contra
All You Need to Know About Motion Acquisition (DCGO) Rating Upgrade to Buy
01:00pm, Monday, 03'rd Mar 2025
Motion Acquisition (DCGO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
DocGo, Inc (DCGO) Q4 2024 Earnings Call Transcript
10:04pm, Thursday, 27'th Feb 2025
DocGo, Inc (NASDAQ:DCGO ) Q4 2024 Results Conference Call February 27, 2025 5:00 PM ET Company Participants Mike Cole - VP of Investor Relations Lee Bienstock - Chief Executive Officer Norman Rosenber
DocGo Inc. (DCGO) Q4 Earnings Beat Estimates
07:15pm, Thursday, 27'th Feb 2025
DocGo Inc. (DCGO) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.06 per share a year ago.
DocGo Expands into Chattanooga Region in Collaboration with Major Tennessee Healthcare System
07:35am, Wednesday, 19'th Feb 2025
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced that its Ambulnz subsidiary ha
DocGo Announces Upcoming Participation at TD Cowen 45th Annual Health Care Conference
07:35am, Tuesday, 18'th Feb 2025
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, announced today that Lee Bienstock, Chief Executive Officer, will p
DocGo to Announce Fourth Quarter and Full Year 2024 Results on Thursday, February 27, 2025
07:35am, Thursday, 13'th Feb 2025
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that the Company will release
DocGo (DCGO) Soars 7.9%: Is Further Upside Left in the Stock?
06:20am, Tuesday, 11'th Feb 2025
DocGo (DCGO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
